How big is the lysosomal storage diseases market?

Lysosomal storage diseases LSDs refer to a group of diseases arising because of the deficiency of lysosomal enzymes which leads to the accumulation of partially digested or undigested macromolecules inside the cell.Market Analysis and Insights Global Lysosomal Storage Diseases MarketThe global Lysosomal Storage Diseases market size is projected to reach US 10460 million by 2028 from US 7436.7 million in 2021 at a CAGR of 4.9 during 20222028.According to the report one driver in the market is unmet medical needs.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Lysosomal Storage Diseases market to help players in achieving a strong market position.

Global Lysosomal Storage Diseases Market Insights and Forecast to 2028

BUY CHAPTERS

Global Lysosomal Storage Diseases Market Insights, Forecast to 2029

Q: Who are the key players in the lysosomal storage diseases market?

Some of the key players are Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research, Horizon Pharma, Leadiant Biosciences, Mylan NV, Others.

Code: QYRE-Auto-34Q5936

Report

August 2023

Pages:112

QYResearch

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Actelion Pharmaceuticals

BioMarin

Genzyme

Takeda

Alexion Pharmaceuticals

Amicus Therapeutics

Chiesi Farmaceutici

Greenovation Biotech And FGK Clinical Research

Horizon Pharma

Leadiant Biosciences

Mylan NV

Lysosomal Storage Diseases Market Size

The global Lysosomal Storage Diseases market is projected to grow from US$ 7847.7 million in 2023 to US$ 10460 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.

Lysosomal Storage Diseases Market

Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.

Market Analysis and Insights: Global Lysosomal Storage Diseases Market

According to the report, one driver in the market is unmet medical needs.

Report Includes

This report presents an overview of global market for Lysosomal Storage Diseases market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Lysosomal Storage Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Lysosomal Storage Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lysosomal Storage Diseases revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Lysosomal Storage Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Lysosomal Storage Diseases revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research and Horizon Pharma, etc.

Scope of Lysosomal Storage Diseases Market Report

Report Metric	Details
Report Name	Lysosomal Storage Diseases Market
Accounted market size in 2023	US$ 7847.7 million
Forecasted market size in 2029	US$ 10460 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Enzyme Replacement Therapy Substrate Reduction Therapy Cystine Depleting Agents
Segment by Application	Hospitals Ambulatory Surgical Centers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Actelion Pharmaceuticals, BioMarin, Genzyme, Takeda, Alexion Pharmaceuticals, Amicus Therapeutics, Chiesi Farmaceutici, Greenovation Biotech And FGK Clinical Research, Horizon Pharma, Leadiant Biosciences, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Lysosomal Storage Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lysosomal Storage Diseases companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lysosomal Storage Diseases revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Enzyme Replacement Therapy

1.2.3 Substrate Reduction Therapy

1.2.4 Cystine Depleting Agents

1.3 Market by Application

1.3.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lysosomal Storage Diseases Market Perspective (2018-2029)

2.2 Global Lysosomal Storage Diseases Growth Trends by Region

2.2.1 Lysosomal Storage Diseases Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Lysosomal Storage Diseases Historic Market Size by Region (2018-2023)

2.2.3 Lysosomal Storage Diseases Forecasted Market Size by Region (2024-2029)

2.3 Lysosomal Storage Diseases Market Dynamics

2.3.1 Lysosomal Storage Diseases Industry Trends

2.3.2 Lysosomal Storage Diseases Market Drivers

2.3.3 Lysosomal Storage Diseases Market Challenges

2.3.4 Lysosomal Storage Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Lysosomal Storage Diseases by Players

3.1.1 Global Lysosomal Storage Diseases Revenue by Players (2018-2023)

3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Players (2018-2023)

3.2 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Lysosomal Storage Diseases, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Lysosomal Storage Diseases Market Concentration Ratio

3.4.1 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Revenue in 2022

3.5 Global Key Players of Lysosomal Storage Diseases Head office and Area Served

3.6 Global Key Players of Lysosomal Storage Diseases, Product and Application

3.7 Global Key Players of Lysosomal Storage Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lysosomal Storage Diseases Breakdown Data by Type

4.1 Global Lysosomal Storage Diseases Historic Market Size by Type (2018-2023)

4.2 Global Lysosomal Storage Diseases Forecasted Market Size by Type (2024-2029)

5 Lysosomal Storage Diseases Breakdown Data by Application

5.1 Global Lysosomal Storage Diseases Historic Market Size by Application (2018-2023)

5.2 Global Lysosomal Storage Diseases Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Lysosomal Storage Diseases Market Size (2018-2029)

6.2 North America Lysosomal Storage Diseases Market Size by Type

6.2.1 North America Lysosomal Storage Diseases Market Size by Type (2018-2023)

6.2.2 North America Lysosomal Storage Diseases Market Size by Type (2024-2029)

6.2.3 North America Lysosomal Storage Diseases Market Share by Type (2018-2029)

6.3 North America Lysosomal Storage Diseases Market Size by Application

6.3.1 North America Lysosomal Storage Diseases Market Size by Application (2018-2023)

6.3.2 North America Lysosomal Storage Diseases Market Size by Application (2024-2029)

6.3.3 North America Lysosomal Storage Diseases Market Share by Application (2018-2029)

6.4 North America Lysosomal Storage Diseases Market Size by Country

6.4.1 North America Lysosomal Storage Diseases Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Lysosomal Storage Diseases Market Size by Country (2018-2023)

6.4.3 North America Lysosomal Storage Diseases Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Lysosomal Storage Diseases Market Size (2018-2029)

7.2 Europe Lysosomal Storage Diseases Market Size by Type

7.2.1 Europe Lysosomal Storage Diseases Market Size by Type (2018-2023)

7.2.2 Europe Lysosomal Storage Diseases Market Size by Type (2024-2029)

7.2.3 Europe Lysosomal Storage Diseases Market Share by Type (2018-2029)

7.3 Europe Lysosomal Storage Diseases Market Size by Application

7.3.1 Europe Lysosomal Storage Diseases Market Size by Application (2018-2023)

7.3.2 Europe Lysosomal Storage Diseases Market Size by Application (2024-2029)

7.3.3 Europe Lysosomal Storage Diseases Market Share by Application (2018-2029)

7.4 Europe Lysosomal Storage Diseases Market Size by Country

7.4.1 Europe Lysosomal Storage Diseases Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Lysosomal Storage Diseases Market Size by Country (2018-2023)

7.4.3 Europe Lysosomal Storage Diseases Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Lysosomal Storage Diseases Market Size (2018-2029)

8.2 China Lysosomal Storage Diseases Market Size by Type

8.2.1 China Lysosomal Storage Diseases Market Size by Type (2018-2023)

8.2.2 China Lysosomal Storage Diseases Market Size by Type (2024-2029)

8.2.3 China Lysosomal Storage Diseases Market Share by Type (2018-2029)

8.3 China Lysosomal Storage Diseases Market Size by Application

8.3.1 China Lysosomal Storage Diseases Market Size by Application (2018-2023)

8.3.2 China Lysosomal Storage Diseases Market Size by Application (2024-2029)

8.3.3 China Lysosomal Storage Diseases Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Lysosomal Storage Diseases Market Size (2018-2029)

9.2 Asia Lysosomal Storage Diseases Market Size by Type

9.2.1 Asia Lysosomal Storage Diseases Market Size by Type (2018-2023)

9.2.2 Asia Lysosomal Storage Diseases Market Size by Type (2024-2029)

9.2.3 Asia Lysosomal Storage Diseases Market Share by Type (2018-2029)

9.3 Asia Lysosomal Storage Diseases Market Size by Application

9.3.1 Asia Lysosomal Storage Diseases Market Size by Application (2018-2023)

9.3.2 Asia Lysosomal Storage Diseases Market Size by Application (2024-2029)

9.3.3 Asia Lysosomal Storage Diseases Market Share by Application (2018-2029)

9.4 Asia Lysosomal Storage Diseases Market Size by Region

9.4.1 Asia Lysosomal Storage Diseases Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Lysosomal Storage Diseases Market Size by Region (2018-2023)

9.4.3 Asia Lysosomal Storage Diseases Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type

10.2.1 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application

10.3.1 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country

10.4.1 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Actelion Pharmaceuticals

11.1.1 Actelion Pharmaceuticals Company Details

11.1.2 Actelion Pharmaceuticals Business Overview

11.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction

11.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.1.5 Actelion Pharmaceuticals Recent Developments

11.2 BioMarin

11.2.1 BioMarin Company Details

11.2.2 BioMarin Business Overview

11.2.3 BioMarin Lysosomal Storage Diseases Introduction

11.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.2.5 BioMarin Recent Developments

11.3 Genzyme

11.3.1 Genzyme Company Details

11.3.2 Genzyme Business Overview

11.3.3 Genzyme Lysosomal Storage Diseases Introduction

11.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.3.5 Genzyme Recent Developments

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Lysosomal Storage Diseases Introduction

11.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.4.5 Takeda Recent Developments

11.5 Alexion Pharmaceuticals

11.5.1 Alexion Pharmaceuticals Company Details

11.5.2 Alexion Pharmaceuticals Business Overview

11.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction

11.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.5.5 Alexion Pharmaceuticals Recent Developments

11.6 Amicus Therapeutics

11.6.1 Amicus Therapeutics Company Details

11.6.2 Amicus Therapeutics Business Overview

11.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction

11.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.6.5 Amicus Therapeutics Recent Developments

11.7 Chiesi Farmaceutici

11.7.1 Chiesi Farmaceutici Company Details

11.7.2 Chiesi Farmaceutici Business Overview

11.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction

11.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.7.5 Chiesi Farmaceutici Recent Developments

11.8 Greenovation Biotech And FGK Clinical Research

11.8.1 Greenovation Biotech And FGK Clinical Research Company Details

11.8.2 Greenovation Biotech And FGK Clinical Research Business Overview

11.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction

11.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.8.5 Greenovation Biotech And FGK Clinical Research Recent Developments

11.9 Horizon Pharma

11.9.1 Horizon Pharma Company Details

11.9.2 Horizon Pharma Business Overview

11.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction

11.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.9.5 Horizon Pharma Recent Developments

11.10 Leadiant Biosciences

11.10.1 Leadiant Biosciences Company Details

11.10.2 Leadiant Biosciences Business Overview

11.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction

11.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.10.5 Leadiant Biosciences Recent Developments

11.11 Mylan

11.11.1 Mylan Company Details

11.11.2 Mylan Business Overview

11.11.3 Mylan Lysosomal Storage Diseases Introduction

11.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2018-2023)

11.11.5 Mylan Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Actelion Pharmaceuticals

BioMarin

Genzyme

Takeda

Alexion Pharmaceuticals

Amicus Therapeutics

Chiesi Farmaceutici

Greenovation Biotech And FGK Clinical Research

Horizon Pharma

Leadiant Biosciences

Mylan NV

List of Tables

Table 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Enzyme Replacement Therapy

Table 3. Key Players of Substrate Reduction Therapy

Table 4. Key Players of Cystine Depleting Agents

Table 5. Global Lysosomal Storage Diseases Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 6. Global Lysosomal Storage Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Lysosomal Storage Diseases Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global Lysosomal Storage Diseases Market Share by Region (2018-2023)

Table 9. Global Lysosomal Storage Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global Lysosomal Storage Diseases Market Share by Region (2024-2029)

Table 11. Lysosomal Storage Diseases Market Trends

Table 12. Lysosomal Storage Diseases Market Drivers

Table 13. Lysosomal Storage Diseases Market Challenges

Table 14. Lysosomal Storage Diseases Market Restraints

Table 15. Global Lysosomal Storage Diseases Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global Lysosomal Storage Diseases Revenue Share by Players (2018-2023)

Table 17. Global Top Lysosomal Storage Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2022)

Table 18. Global Lysosomal Storage Diseases Industry Ranking 2021 VS 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Revenue (CR5 and HHI) & (2018-2023)

Table 20. Global Key Players of Lysosomal Storage Diseases, Headquarters and Area Served

Table 21. Global Key Players of Lysosomal Storage Diseases, Product and Application

Table 22. Global Key Players of Lysosomal Storage Diseases, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global Lysosomal Storage Diseases Revenue Market Share by Type (2018-2023)

Table 26. Global Lysosomal Storage Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global Lysosomal Storage Diseases Revenue Market Share by Type (2024-2029)

Table 28. Global Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global Lysosomal Storage Diseases Revenue Share by Application (2018-2023)

Table 30. Global Lysosomal Storage Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global Lysosomal Storage Diseases Revenue Share by Application (2024-2029)

Table 32. North America Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)

Table 33. North America Lysosomal Storage Diseases Market Size by Type (2024-2029) & (US$ Million)

Table 34. North America Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 35. North America Lysosomal Storage Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 36. North America Lysosomal Storage Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. North America Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)

Table 38. North America Lysosomal Storage Diseases Market Size by Country (2024-2029) & (US$ Million)

Table 39. Europe Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)

Table 40. Europe Lysosomal Storage Diseases Market Size by Type (2024-2029) & (US$ Million)

Table 41. Europe Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 42. Europe Lysosomal Storage Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 43. Europe Lysosomal Storage Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Europe Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)

Table 45. Europe Lysosomal Storage Diseases Market Size by Country (2024-2029) & (US$ Million)

Table 46. China Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)

Table 47. China Lysosomal Storage Diseases Market Size by Type (2024-2029) & (US$ Million)

Table 48. China Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 49. China Lysosomal Storage Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 50. Asia Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)

Table 51. Asia Lysosomal Storage Diseases Market Size by Type (2024-2029) & (US$ Million)

Table 52. Asia Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 53. Asia Lysosomal Storage Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 54. Asia Lysosomal Storage Diseases Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 55. Asia Lysosomal Storage Diseases Market Size by Region (2018-2023) & (US$ Million)

Table 56. Asia Lysosomal Storage Diseases Market Size by Region (2024-2029) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type (2018-2023) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Type (2024-2029) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application (2018-2023) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Application (2024-2029) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Lysosomal Storage Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 62. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country (2018-2023) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size by Country (2024-2029) & (US$ Million)

Table 64. Actelion Pharmaceuticals Company Details

Table 65. Actelion Pharmaceuticals Business Overview

Table 66. Actelion Pharmaceuticals Lysosomal Storage Diseases Product

Table 67. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 68. Actelion Pharmaceuticals Recent Developments

Table 69. BioMarin Company Details

Table 70. BioMarin Business Overview

Table 71. BioMarin Lysosomal Storage Diseases Product

Table 72. BioMarin Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 73. BioMarin Recent Developments

Table 74. Genzyme Company Details

Table 75. Genzyme Business Overview

Table 76. Genzyme Lysosomal Storage Diseases Product

Table 77. Genzyme Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 78. Genzyme Recent Developments

Table 79. Takeda Company Details

Table 80. Takeda Business Overview

Table 81. Takeda Lysosomal Storage Diseases Product

Table 82. Takeda Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 83. Takeda Recent Developments

Table 84. Alexion Pharmaceuticals Company Details

Table 85. Alexion Pharmaceuticals Business Overview

Table 86. Alexion Pharmaceuticals Lysosomal Storage Diseases Product

Table 87. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 88. Alexion Pharmaceuticals Recent Developments

Table 89. Amicus Therapeutics Company Details

Table 90. Amicus Therapeutics Business Overview

Table 91. Amicus Therapeutics Lysosomal Storage Diseases Product

Table 92. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 93. Amicus Therapeutics Recent Developments

Table 94. Chiesi Farmaceutici Company Details

Table 95. Chiesi Farmaceutici Business Overview

Table 96. Chiesi Farmaceutici Lysosomal Storage Diseases Product

Table 97. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 98. Chiesi Farmaceutici Recent Developments

Table 99. Greenovation Biotech And FGK Clinical Research Company Details

Table 100. Greenovation Biotech And FGK Clinical Research Business Overview

Table 101. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product

Table 102. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 103. Greenovation Biotech And FGK Clinical Research Recent Developments

Table 104. Horizon Pharma Company Details

Table 105. Horizon Pharma Business Overview

Table 106. Horizon Pharma Lysosomal Storage Diseases Product

Table 107. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 108. Horizon Pharma Recent Developments

Table 109. Leadiant Biosciences Company Details

Table 110. Leadiant Biosciences Business Overview

Table 111. Leadiant Biosciences Lysosomal Storage Diseases Product

Table 112. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 113. Leadiant Biosciences Recent Developments

Table 114. Mylan Company Details

Table 115. Mylan Business Overview

Table 116. Mylan Lysosomal Storage Diseases Product

Table 117. Mylan Revenue in Lysosomal Storage Diseases Business (2018-2023) & (US$ Million)

Table 118. Mylan Recent Developments

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Lysosomal Storage Diseases Market Share by Type: 2022 VS 2029

Figure 3. Enzyme Replacement Therapy Features

Figure 4. Substrate Reduction Therapy Features

Figure 5. Cystine Depleting Agents Features

Figure 6. Global Lysosomal Storage Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 7. Global Lysosomal Storage Diseases Market Share by Application: 2022 VS 2029

Figure 8. Hospitals Case Studies

Figure 9. Ambulatory Surgical Centers Case Studies

Figure 10. Lysosomal Storage Diseases Report Years Considered

Figure 11. Global Lysosomal Storage Diseases Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Lysosomal Storage Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Lysosomal Storage Diseases Market Share by Region: 2022 VS 2029

Figure 14. Global Lysosomal Storage Diseases Market Share by Players in 2022

Figure 15. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2022

Figure 17. North America Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Lysosomal Storage Diseases Market Share by Type (2018-2029)

Figure 19. North America Lysosomal Storage Diseases Market Share by Application (2018-2029)

Figure 20. North America Lysosomal Storage Diseases Market Share by Country (2018-2029)

Figure 21. United States Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Lysosomal Storage Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Lysosomal Storage Diseases Market Share by Type (2018-2029)

Figure 25. Europe Lysosomal Storage Diseases Market Share by Application (2018-2029)

Figure 26. Europe Lysosomal Storage Diseases Market Share by Country (2018-2029)

Figure 27. Germany Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Lysosomal Storage Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Lysosomal Storage Diseases Market Share by Type (2018-2029)

Figure 35. China Lysosomal Storage Diseases Market Share by Application (2018-2029)

Figure 36. Asia Lysosomal Storage Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Lysosomal Storage Diseases Market Share by Type (2018-2029)

Figure 38. Asia Lysosomal Storage Diseases Market Share by Application (2018-2029)

Figure 39. Asia Lysosomal Storage Diseases Market Share by Region (2018-2029)

Figure 40. Japan Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Lysosomal Storage Diseases Market Share by Country (2018-2029)

Figure 50. Brazil Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Lysosomal Storage Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 57. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 58. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 59. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 60. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 61. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 62. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 63. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 64. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 65. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 66. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2018-2023)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Lysosomal Storage Diseases Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-34Q5936

Global Lysosomal Storage Diseases Market Insights, Forecast to 2029

FEATURED COMPANIES

Lysosomal Storage Diseases Market Size

Lysosomal Storage Diseases Market

Scope of Lysosomal Storage Diseases Market Report

Chapter Outline

FEATURED COMPANIES

RELATED REPORTS